Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference
For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week.
All Work
Chris Lange
American Express, IBM, Intel, Johnson & Johnson and More Dow Stocks Reporting This Week
24/7 Wall St. has put together a preview of American Express, Intel, Procter & Gamble and the other Dow companies scheduled to report their quarterly results this week.
American Airlines, Netflix, Starbucks and More Major Earnings This Week
24/7 Wall St. has put together a preview of AbbVie, American Airlines, Netflix, Starbucks and some of the other most prominent earnings reports due in this truncated trading week.
This Week’s Biggest Biotech Movers
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
2 Years After Equifax Data Breach, Is All Now Forgiven?
While Equifax suffered after its hack, it has recovered since, and one independent research firm believes the stock can break out further from here.
Why Schlumberger Earnings Were So Great
Schlumberger released better than expected fourth-quarter financial results before the markets opened on Friday.
Will Hexo’s Direct Offering Help Push the Stock Higher?
Hexo shares slid on Friday after the Canadian cannabis firm announced that it is conducting a direct offering of $20 million worth of shares.
What’s Next for Durect After FDA Posimir Vote
Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.
Does CSX Deserve More Credit for Its Q4 Earnings Beat?
CSX shares fell after it released mixed fourth-quarter financial results after the markets closed on Thursday.
Can Nike Outrun a Ban on Its Latest Shoes?
Nike has made great strides over the past year, not only with its shares up incredibly but also its new Vaporfly Next% shoes have dominated the running scene.
Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?
Neon Therapeutics shares shot up on Thursday after the firm announced that it will be acquired by BioNTech. Are Neon Therapeutics shareholders getting enough out of the deal?
Is This the Quarter Schlumberger Turns It Around?
Schlumberger is scheduled to release its fourth-quarter financial results before the markets open on Friday.
How Morgan Stanley Won Big in Q4
Morgan Stanley stock rose after it released better than expected fourth-quarter financial results early Thursday.
Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
Does FDA Decision Mean a Bright Future for This Flu Vaccine?
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
Will Trading Revenues Play a Big Role in Morgan Stanley’s Q4 Report?
Morgan Stanley is set to release its most recent quarterly numbers before the opening bell on Thursday. How big a role will trading revenue play in the results?
Is It Time to Take Profits on Bank of America After Earnings?
Bank of America reported mixed fourth-quarter financial results before the markets opened on Wednesday. Is it time to take profits?
Does UnitedHealth Deserve More Credit for Q4?
When UnitedHealth reported mixed fourth-quarter financial results before the markets opened on Wednesday.
Is Goldman Sachs Poised for a Big Win?
Goldman Sachs is set to report its most recent quarterly results before the markets open on Wednesday.
Will 2020 Be the Breakout Year for Amazon?
Although Amazon.com stock has not kept pace with markets over the past year, a couple analysts are calling for shares to run much higher.